Business Context and Reporting Period
Company: AMBEV S.A.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: First Quarter ended March 31, 2021 (1Q21)
Accounting Standards: International Financial Reporting Standards (IFRS) and Brazilian Accounting Standards (CPC).
Context: Ambev reported results amidst ongoing COVID-19 restrictions, though with gradual easing in many markets. The company applied Hyperinflation Accounting (IAS 29) to its Argentinean subsidiaries.
Key Financial Metrics
| Metric (R$ million) | 1Q20 | 1Q21 | % Change (As Reported) | % Change (Organic) |
|---|---|---|---|---|
| Net Revenue | 12,602.6 | 16,639.8 | 32.0% | 27.8% |
| Volume ('000 hl) | 39,011.5 | 43,530.2 | 11.6% | 11.6% |
| Net Revenue per hl (R$) | 323.0 | 382.3 | 18.3% | 14.5% |
| Gross Profit | 6,959.4 | 8,694.4 | 24.9% | 21.6% |
| Gross Margin | 55.2% | 52.3% | -290 bps | -260 bps |
| Normalized EBITDA | 4,232.5 | 5,327.2 | 25.9% | 23.8% |
| Normalized EBITDA Margin | 33.6% | 32.0% | -160 bps | -110 bps |
| Normalized Profit | 1,227.8 | 2,761.9 | 124.9% | N/A |
| Normalized EPS (R$) | 0.07 | 0.17 | 139.6% | N/A |
| Cash Flow from Operating Activities | 1,544.1 | 2,836.9 | 83.7% | N/A |
| CAPEX | 1,346.3 | 1,327.3 | -1.4% | N/A |
| Net Debt/(Cash) | (13,998.1) | (14,308.5) | N/A | N/A |
Note: Negative Net Debt indicates a net cash position.
Material Changes vs. Prior Period
- Revenue Growth: Driven by volume growth of 11.6% and Net Revenue per hectoliter (NR/hl) growth of 14.5%. Growth was broad-based: Brazil (+26.1%), Central America & Caribbean (CAC) (+28.2%), Latin America South (LAS) (+44.0%), and Canada (+1.6%).
- Cost Pressures: Cost of Goods Sold (COGS) increased 35.3% (21.3% per hl) due to transactional currency headwinds, rising commodity prices, package mix impacts, and inflation in Argentina. Cash COGS per hl rose 24.2%.
- Expense Management: SG&A expenses rose 13.9%, driven by variable compensation provisions and higher distribution costs (including direct-to-consumer expansion), partially offset by phased Sales & Marketing expenses.
- Profitability: Despite margin compression (Gross margin -260bps; EBITDA margin -110bps), Normalized Profit more than doubled (+124.9%) due to significant top-line recovery and improved financial results.
- Financial Results: Net finance results improved by R$ 472.6 million compared to 1Q20, aided by a R$ 251.8 million non-cash gain from Hyperinflation Accounting in Argentina, though offset by R$ 770.9 million in derivative losses.
Guidance, Outlook, and Risks
- 2021 Outlook: Management expects 2021 to remain challenging and volatile due to COVID-19. The strategy focuses on innovation, technology-driven transformation, and operational excellence.
- Margin Expectations: Margin pressure is expected to persist in Brazil due to FX/commodity headwinds and increased SG&A (variable compensation). However, top-line recovery is expected to drive normalized consolidated EBITDA performance toward 2019 levels.
- Recovery Path: The company anticipates top-line recovery will precede bottom-line recovery. International performance is expected to remain strong.
- Risks & Contingencies:
- COVID-19: Ongoing restrictions and potential reinstatement (as seen in March in Brazil and LAS) impact on-premise consumption.
- Hyperinflation: Continued application of IAS 29 in Argentina introduces volatility in reported results due to currency translation and indexation.
- Commodities & FX: Exposure to commodity price fluctuations and foreign exchange rates (specifically Argentine Peso and Brazilian Real depreciation).
- Unusual Items: Exceptional items totaled R$ 71.4 million in 1Q21 (vs. R$ 24.1 million in 1Q20), primarily related to COVID-19 pandemic expenses (R$ 31.1 million) and restructuring (R$ 39.2 million).
Investor Verification Checklist
- Argentina Hyperinflation Impact: Verify the specific impact of IAS 29 indexation and currency translation on the reported revenue and EBITDA figures for the LAS segment.
- Margin Sustainability: Assess the durability of the 14.5% NR/hl growth against rising commodity costs and FX headwinds in the full-year outlook.
- On-Premise Recovery: Monitor the trajectory of on-premise channel reopening in Brazil and LAS, as this significantly impacts volume and mix.
- Derivative Exposure: Review the R$ 770.9 million loss on derivative instruments and the hedging strategy for FX and commodity exposure.
- Cash Position: Confirm the net cash position of R$ 14.3 billion and the company's ability to maintain liquidity amidst potential further pandemic-related disruptions.